« Return to News | Study Conduct

Synexus expands presence in South Africa

Wednesday, July 18, 2012 01:21 PM

Synexus has further expanded its global presence with the opening of a new in-patient facility in Pretoria, South Africa. Synexus now has a total of four sites in South Africa, which provide access to millions of patients.

The Nyeleti research facility (‘Nyeleti' meaning ‘STAR' in Sotho) has been developed for phase II and III studies that involve 24-hour serial spirometry (lung function), mixed meal tolerance testing, PK visits requiring an overnight stay or when infusion is required. This new site will support the existing Synexus clinical trial centers in Pretoria and Mamelodi.

The facility includes an in-patient ward as well as a secure, temperature-controlled dispensing unit designed to manage supplies according to ICH, GCP and national guidelines. It also houses emergency and other resuscitative equipment, a transit laboratory and food preparation area and has ambulance support.

“Synexus recognizes the vital role South Africa has to play in global clinical trials and continues to invest in the region,” said Dr. Christophe Berthoux, CEO of Synexus. “In addition to providing access to a large patient pool, many of whom are treatment naive, the medical infrastructure and training is of a very high standard. There is also a high public awareness of the benefits of clinical trials, which speeds up recruitment and overcomes the lengthy regulatory process. These are all key factors in ensuring the success of a clinical trial."

Dr. Sanet Aspinall, managing director of Synexus South Africa, said, "We are well positioned to continue our success as the leading professional investigator organization in South Africa that meets, and often exceeds, our clients' needs in conducting phase II-IV studies.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.